UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Life Science

Digital Pathology: Lagging or Leading?

When compared to traditional methods, digital pathology may seem totally superfluous, or interesting but not all that essential. And since the costs for the elegance of digital pathology solutions are not trivial in comparison to what the peddlers traditionally have offered, it is not surprising to see the adoption curve lagging. Where then is the ‘burning platform’ that can truly drive greater adoption of digital pathology? 

Read More

Understanding the gut-liver axis: implications for NAFLD prevention and treatment

You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.

Read More

Automatic AI-powered Tumor Budding

Tumor Budding has been shown in numerous studies to be an independent prognostic factor in colorectal cancer (CRC) for the risk of distant metastasis and, in stage II CRC, for overall survival. Fraunhofer IIS and the Institute for Pathology, University Hospital Erlangen are developing an AI system to automatically detect tumor budding in CRC patients.

Read More

How to beneficially modulate vaginal microbiota to optimise women’s health

Each woman has a unique vaginal microbiota composition, which is dynamic and affected by diet, lifestyle, hormones, genetics, and age. In the past decade, exploration of the human microbiota has focused increasingly on vaginal microbiota composition and diversity and its impact on health, reproduction, and disease.

Read More

Digital Pathology in Drug Development: Opportunities and Challenges

We recently caught up with Dr Olulanu Aina, Scientific Director and Veterinary and Toxicological Pathologist at Janssen, about digital pathology applications in drug discovery...

Read More

Gut-brain axis insights: why the microbiota holds therapeutic potential for neuro-developmental disorders

Evidence is emerging that there are important connections between the gut microbiome and neurodevelopmental disorders. In a guest post for World Autism Awareness Month this April, Chris Kenji Beer reviews recent discoveries.

Read More

Probiotics save the gut microbiome from antibiotics

Antibiotics consumption is increasing worldwide, yet these therapies not only destroy pathogens but also damage our vital intestinal flora.

Read More

Hafnia alvei HA4597™ – a new clinically validated solution in weight management

Hyperphagia is a common underlying cause of overweight and obesity. However, the dieting approaches towards weight loss are usually ineffective due to a persistent increase in appetite. Most of the current products in weight management are based on the principle of sugar/fat blockers and binders which has proven to be rather short-term solution.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Archive